Skip to main content

Loading market ticker...

Nectar Lifesciences

Healthcare NSE:NECLIFE

11.63INR
-0.45 ( -3.73%)

Last update at June 18, 2026, midnight

Day Range

11.4912.24
LowHigh

52 Week Range

13.05 41.00
LowHigh

Fundamentals

  • Previous Close 12.08
  • Market Cap 3889.15M
  • Volume611,867
  • P/E Ratio -
  • EBITDA -1287.91M
  • Revenue TTM 15917.92M
  • Revenue Per Share TTM 71.32
  • Gross Profit TTM 1975.85M
  • Diluted EPS TTM -8.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1427.60 15/05/26 15/05/26 Same Day Short Term Healthcare 0.17%
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax -1615.34M 182.69M -424.20M 340.80M -847.67M
Net income -1136.81M 49.95M -241.83M 250.47M -732.64M
Total Revenue 16699.74M 16840.86M 15236.70M 16688.32M 15432.97M
Gross Profit 3019.64M 4818.44M 3643.85M 2993.27M 2575.70M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 20472.31M 21910.56M 21892.11M 23908.32M 24711.19M
Intangible assets 565.04M 523.93M 493.29M 430.21M 383.65M
Other current assets 1738.22M 645.76M 2189.49M 45.89M 53.05M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -5.84M 22.26M -2.28M -77.31M 42.45M
Operating Cash 1694.38M 2246.86M 1336.51M 950.05M 213.79M
Free Cash Flow 1256.43M 1952.71M 1035.91M 700.35M -98.62M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
NECLIFE
Nectar Lifesciences 		-0.45 -3.73% 11.63 3889.15 -
SUNPHARMA
Sun Pharmaceutical Industries Limited 		4.40 0.24% 1824.80 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		103.50 1.55% 6767.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		2.70 0.06% 4445.50 1362716.66 63.48
CIPLA
Cipla Limited 		4.70 0.35% 1355.50 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.